Market Size (2014)
2014
$841.20M
Healthcare
Test Safety Lancet Market
By Segment, By Region, And Segment Forecasts, 2014 – 2023
Vertical: HealthcareBase Year: 201611 Sections
Executive Summary
Test Safety Lancet Market — Snapshot
Projected (2023)
2023
$2.00M
CAGR (2014–2023)
-48.9%
-48.9%Key Players
105+
Safety lancets are one of the widely used alternative device to obtain the blood samples. Lancets are receiving global recognition and acceptance due to its several convenient characteristics which gives them an edge over the traditional methods for vein puncture. Some of important features of the safety lancets are painless vein puncture, easy handling and safety while using. The major applications of the safety lancets are capillary blood micro sampling, cholesterol test, HBO and HIV screening test, blood group test, coagulation tests, allergy tests and many other blood based tests.
Safety lancets are introduced in 1994 by Medlance with the initiation button and T-shape cover over it. They are useful to avoid needle-stick injuries and infections. In United States alone in 2014, around 2.2 million people had chronic hepatitis B virus infection. (CDC, Viral Hepatitis - Hepatitis B Information, 2016). To reduce the prevalence of such blood borne infections, safety lancets are very helpful. Safety lancets can be further classified by their structural specifications such as Push Button Safety Lancets, Pressure Activated Safety Lancets and Side Button Safety Lancets. Companies like HTL-STREFA S.A. Medline Industries, Inc. and Sarstedt AG & Co are some of the major manufacturers of safety lancets.
Increasing awareness of Safety Lancet:
Rising prevalence of diabetic population, increased awareness for blood glucose monitoring device (homecare) and increased awareness of safety measures in order to avoid the infectious diseases are some of the significant factors of the increased awareness and use of lancets.
Production of Safety Lancet:
A large number of safety lancet manufacturers are from developing Asian countries such as China, India, Japan and Republic of Korea mainly because of the low labour cost and low R&D cost. China being one of the highly populated and technologically advanced developing countries, has a major number of lancets manufacturers. Some of the renowned Chinese Safety Lancet manufacturers are Guangzhou Improve Medical Instruments Co, Huang and KDL China. HTL Strefa and Sarstedt are two European companies which have marked their presence on the global level as a major manufacturer of Safety Lancets in the world.
The market for safety lancets is growing rapidly. Increasing prevalence of needle-stick injuries and rising awareness of safety lancet applications are the driving factors of the safety lancet market. The market for safety lancets by type is segmented into Push Button Safety Lancets, Pressure Activated Safety Lancets and Side Button Safety Lancets, in which Push Button Safety Lancets accounts for the largest market share in 2016 as there is a growing need for safe blood glucose test in hospitals and the growth of insulin users. Push Button Safety Lancets is projected to grow at the fastest CAGR of 12.28% during the forecast period from 2017-2023.
Additionally, the market is further segmented on the basis of end user and is bifurcated into Hospitals & Clinics, Diagnostic Canters and Pathology Laboratories, Home Diagnostics and others. Out of which hospital & clinics holds the largest market share among the all the end users. Diagnostic canters and pathology laboratories is the second largest segment in Global Safety lancets market, by End User as growing prevalence of diabetes around the globe, improving healthcare regulations for medical devices is driving the growth of the safety lancet market by end users. The global safety lancets market by end user is expected to reach USD 2,305.1 million in the year 2023 from USD 1,056.2 million 2016.
On the basis of region the market is segmented into North America, Europe, Asia-Pacific and Middle East and Africa. Europe region captured the largest market globally is expected to USD 1,032.7 million by 2023 as the growing demand and need for safe blood glucose tests in hospitals, clinics, diagnostics centers etc. and the growth of insulin users. In addition the European market is supported by increasing regulatory and safety standards in developed and developing markets. Asia-Pacific region is projected to be the fastest growing at a CAGR of 12.40% during the forecast period from 2017-2023.
The market in this report would cover market based on safety lancet types, end users and regions. The global market of lancets is dominated by several major players such as HTL-STREFA S.A, BD, Bayer, LifeScan, KDL China, Medline, Sarstedt and others.
Key Insight
The Test Safety Lancet Market market is projected to grow at a CAGR of -48.9% from 2014 to 2023.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 4 regions: Middle East and Africa, North America, Asia Pacific, Europe.
- Market Segmentation: The market is analyzed across key segments with forecasts from 2014 to 2023.
- Competitive Landscape: 105 leading companies are profiled, covering market positioning, strategies, and recent developments.
Market Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
Test Safety Lancet Market — Growth Trajectory
Safety lancets are single-use gadgets/devices for narrow blood testing used by professionals in healthcare services. They are a necessary part to the sharps-injury aversion programs in hospitals, clinics, research centers, physicians’ offices and wherever both patients and experts need to feel safe. Needle-stick wounds and diseases can be avoided by utilizing Safety lancets. Some of the features of safety lancets are they are simple to use, they have color-coded product versions to meet specific blood sample applications and address the variety of patient skin types and simple and easy to handle.
Globally lancets are being utilized by patients who are affected by endocrine related complications, cardiovascular issues and many other issues. Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients.
The global market of safety lancets is growing rapidly because of the rising prevalence of diabetes and growing number of blood borne diseases across the globe. The global market of safety lancets is expected to reach USD 2,305.1 million in 2023 from USD 1,056.2 million in 2016 with a CAGR of 11.8 %.
The major players of the market are HTL Strefa, Sarstedt AG & Co., Terumo Corporation, BD, Guangzhou Improve Medical Instruments Co., Ltd and others. APAC region was the most benefited region due to the increased use of lancets, because of its huge population and lower labour cost.
Market Size Trend (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- Type Type is broken down into: Push Button Safety Lancets, Pressure Activated Safety Lancets, Side Button Safety Lancets.
- End Users End Users is broken down into: Hospitals & Clinics, Diagnostic Canters and Pathology Laboratories, Home Diagnostics, Others.
Geographic Analysis
Regional market breakdown
- Middle East and Africa Middle East and Africa market size reached $50.20M in 2014 and is projected to reach $79.70M by 2023, growing at a CAGR of 5.3%.
- North America North America market size reached $302.20M in 2014 and is projected to reach $843.00M by 2023, growing at a CAGR of 12.1%.
- Asia Pacific Asia Pacific market size reached $122.00M in 2014 and is projected to reach $349.60M by 2023, growing at a CAGR of 12.4%.
- Europe Europe market size reached $366.80M in 2014 and is projected to reach $1.00M by 2023, growing at a CAGR of -48.1%.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
Test Safety Lancet Market — How We Researched This Market
This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2016
Historical Period
2014 – 2016
Forecast Period
2016 – 2023
Primary Interviews
150+
Research Process
Historical data (2014–2016) and forecast period (2016–2023)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Historical vs. Forecast Data
Historical (observed)
Forecast (modelled)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCompetitive Landscape & Porter's Five Forces
Test Safety Lancet Market — Competitive Analysis
Bargaining Power of Suppliers
The suppliers in the global safety lancet industry are the developers and manufacturers of safety lancet. There are a high number of suppliers in the global safety lancet market thus leading to an averagely high amount of bargaining power in the market. Switching cost of these suppliers is average as suppliers tend to enter into long term associations with the safety lancet manufacturers. However, the Asian countries are consisting of large number of suppliers which offer these safety lancet at a relatively economical price. Due to moderately high bargaining power of suppliers the profit potential of the global safety lancet industry is reduced.
Bargaining Power of Buyers
The bargaining power of safety lancet buyers is moderate in the global safety lancet market, this is because of the large number of economical safety lancet providers in the industry. There are a large number of manufacturers or suppliers of safety lancet present in the industry which makes it a highly competitive market. Hence, availability of more number of manufacturers expands the selection arena of the sellers for the buyers, which leads to the increasing bargaining power.
Threat of New Entrants
Threat of new entrants is moderately low in the global safety lancet market. Any manufacturing company trying to enter the market is required to accept the mandatory regulatory standards as per the current reclassification of safety lancet by FDA. The Safety lancet market is also characterized by a reasonable degree of brand loyalty where establishing a brand name is difficult for newcomers. However, the cost involved in manufacturing setup is low to medium which discreetly comfort the new entrants to enter in the market easily.
Threat of Substitutes
Threat of substitutes in the global safety lancet market is very low. Buyer’s propensity to substitute is less due to low availability of substitutes in this market. In addition, the low degree of switching cost minimizes the threat of substitutes.
Intensity of Rivalry
The degree of competition in the global safety lancet market is considered to be moderate. The reserved degree of product differentiation among existing players increases the intensity of rivalry in the market. Safety lancet manufacturing companies are trying to develop products with high quality and enhanced safety in order to increase the demand for these products in developed countries and developing regions. To overcome the competition, players are engaged in developing process to lower their manufacturing cost. Moreover, the players are also developing advanced products for differentiating their brand from their competitors
Quantitative Analysis
Regional Breakdown
Regional market breakdown for Test Safety Lancet Market.
Regional Market Size (USD Mn)
Market estimates by geography (2023)
USD Mn
InsightNorth America leads with $843.00M by 2023, while Asia Pacific is projected to grow fastest at a 12.4% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRegional Market Data
| REGION | 2014 | 2016 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $50.20M | $67.30M | $79.70M | 5.3% | 6% |
| North America | $302.20M | $533.20M | $843.00M | 12.1% | 66% |
| Asia Pacific | $122.00M | $218.50M | $349.60M | 12.4% | 27% |
| Europe | $366.80M | $650.60M | $1.00M | -48.1% | 0% |
| Total | $841.20M | $1.47B | $1.27B | -48.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansEmpower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
Test Safety Lancet Market — Key Findings
Analytical insights on Test Safety Lancet Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
The Test Safety Lancet Market market is projected to reach $2.00M by 2023, growing at -48.9% CAGR.
Market Dynamics
The global safety lancet market has been identified as one of the fastest growing industries, owing to the changing dynamics of the legal and regulatory framework and the intense competitive rivalry among a plethora of public companies. The following segment will discuss the key market driving and restraining forces.
Market Drivers
Developing contagious and non-contagious diseases can be characterized as diseases that have recently appeared in a population or have existed however are quickly expanding in incidence or geographic range. Hantavirus pulmonary syndrome, HIV/AIDS, Lyme disease, hemolytic uremic syndrome among others.
Incidence of contagious diseases is increasing rapidly on a global level. According to WHO, it has been calculated that, infectious diseases for example plaque which is also known as black death has an estimated 50 million deaths in the 14th century, this infectious disease can be a serious disease if not treated, this disease has a case fatality ratio of around 30%-60%, as of 2013 there were 783 cases worldwide which includes 126 deaths.
Thus with growing incidence of contagious and non-contagious diseases the demand for common tests such as blood tests, urine tests etc. would increase and devices used for these tests will increase, as a result there will be a lift in the global market of lancets.
Market Restraints
Every medical process involves potential benefits to the patient as well as possible risks. These risks must be examined whenever transfusion of blood or blood components is considered. Having an allergic reaction to the donated blood is an unusual problem of blood transfusion. However in 2013 there were approximately 320 cases of allergic reactions after blood transfusion in the UK, these allergic reactions are caused due to the body’s immune system which reacts to substances such as proteins in the donated blood. The reactions of the allergic reactions are usually mild but can be harmful if not attended with proper medical care.
Some other risks associated with blood transfusion are anaphylaxis, Lung injury, fluid overload, bacterially contaminated blood, Haemolytic reactions and viral contaminated blood.
Thus with such risks associated with blood transfusion people may hesitate to go through the process or use related products in the blood transfusion procedure like blood lancets, safety lancets, etc. Therefore such risk associated factors may restrain the growth of global safety lancet market.
Strategic Outlook and Future Directions
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Companies
Key companies profiled in Test Safety Lancet Market
Profiles of 105 companies operating in the Test Safety Lancet Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
Improve Me
Improve Medical Technology Co. Ltd
Healthcare
Incorporated in 1996 and headquarters in United States, Guangzhou Improve Medical Instruments Co., Ltd which is also referred to as Improve Medical, is a global company which provides appropriate products, services and technologies in the field of clinical laboratories and clinical nursing. The company is one of the leading companies in domestic high-end market and one of the leading suppliers in the field of Evacuated Blood Collection System in the world. The major products of the company include products like Improvacuter, Impromini, Improswab, Impronurse, Longx etc. The company operates in more than 90 countries globally and has a work force of around 1000 employees.
RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Sarstedt A
Sarstedt AG & Co.
Healthcare
Established in 1961 and headquarters in Germany, Sarstedt AG & Co is one of the world’s largest manufacturers and developers of medical and laboratory equipment. The company aims to provide its customers with highly efficient and high quality products. Sarstedt AG & Co involves 31 sales organizations in Europe and 13 production sites in North America, Europe and Australia. The company has an employee work force of around 2500 employees.
RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
HTL-STREFA
HTL-STREFA S.A.
Healthcare
HTL-STREFA S.A. is a Poland based medical device company which was incorporated in the year 1995. It is world’s leading medical device company that develops manufactures and sells safety lancets, personal lancets, and pen needles for insulin injection. They have a wide range of products which includes safety lancets, pen needles, personal lancets and lancing devices. They have an experienced team of employees that continuously improvise on their strategy for analysing and updating their products. They are implementing improvements and launching new solutions to meet the changing needs of both patients and health care professionals. Some of the competitors of HTL STREFA are Owen Mumford Ltd., SHL Group, IDEO LLC, and Victoza among others. HTL-STREFA S.A. is headquartered in Poland having the employee strength of more than 1170 spread over more than 80 countries around the world. The company generated net sales of 68 million EURO in 2015.
Revenue$58.4B
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Terumo Med
Terumo Medical Corporation
Healthcare
Company Headquarters: Tokyo, Japan Founded: 1921 Workforce: 25,000 Company Working: Terumo Medical Corporation delivers innovative health solutions and provides breakthrough solutions and technologies. The company is involved in manufacturing and sales of medical products and equipment, such as pharmaceuticals, nutritional food supplements, disposable medical devices, vascular grafts, and blood glucose monitoring systems, among others. It has a market presence in over 160 countries in the world. It operates its business through three segments, namely, cardiac and vascular company, blood management company, and general hospital company. Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies. TIS offers a complete, solution-based product portfolio used in advanced coronary, peripheral endovascular and urological treatments with strategic initiatives in Transradial Access, Complex Coronary Intervention, Peripheral Artery Disease and Embolotherapy.
Revenue$4.2B
Employees25,000
Market CapN/A
Founded1920
Tokyo, Japan
F. HOFFMAN
F. HOFFMANN-LA ROCHE LTD
Healthcare
Incorporated in 1896 and headquarters in Basel, Switzerland; F. Hoffmann-La Roche AG is the world's biggest biotech organization, with genuinely differentiated solutions in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is additionally the world pioneer in vitro diagnostics and tissue-based cancer diagnostics, and a leader in diabetes management. The consolidated qualities of pharmaceuticals and diagnostics under one rooftop have made Roche the pioneer in personalized healthcare. The products offered by the company helps in tapping in the world’s two third of all the diseases which are either not treated effectively or not treated at all. The company offers various products in the Pharmaceutical, Diagnostics and research industry. Geographically the company operates in North America, Europe, South America, Africa, Asia and Oceania. As of 2015 F. Hoffmann-La Roche AG had a head count of 91,700 + employees world wide Roche Strategy – a methodology that intends to fit the right treatment to every patient in the most ideal way that could be available dedicated on developing innovative diagnostic tests and medicines which will help their patients and the world.
Revenue$63.3B
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Novavax, I
Novavax, Inc.
Healthcare
Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa
Revenue$0.5B
Employees2,500
Market CapN/A
Founded1986
Maryland, US
Page 1 of 18
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Test Safety Lancet Market
Starting from
$4,950